REST Complex Dysregulation as Master Epigenetic Switch: The RE1-silencing transcription factor (REST) has been proposed as a master epigenetic switch whose dysregulation contributes to neurodegeneration. However, the evidence presents a nuanced picture. REST has been reported as a stress-resistance factor in aging and Alzheimer disease, making the direction of REST modulation more complex than a simple pathogenic master-switch model. Furthermore, REST localization varies across brain regions and disease stages in aging and Alzheimer disease models, arguing against a uniform single-switch interpretation. These findings suggest that REST dysregulation may be context-dependent rather than representing a uniform pathogenic mechanism.
Curated pathway from expert analysis
flowchart TD
A["REST/NRSF Transcriptional Repressor<br/>Neuronal Gene Silencing Factor"]
B["GABAergic and Synaptic Gene Suppression<br/>Non-neuronal Cell Identity Maintenance"]
C["Tau and ATXN2 Modulation<br/>Neurodegeneration Linkage"]
D["REST Deficiency in Aging<br/>Neurotoxic Gene Derepression"]
E["Neuronal Identity Loss<br/>Synaptic Vulnerability"]
F["REST Activating Compounds<br/>Neuroprotective Target Validation"]
G["AD and FTD Mechanisms<br/>REST-Dependent Protection Failure"]
A --> B
B --> C
C --> D
D --> E
E --> F
F --> G
style A fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style F fill:#1b5e20,stroke:#81c784,color:#81c784No linked papers recorded for this hypothesis yet.
No curated PDB or AlphaFold mapping for REST yet. Search RCSB →
Median TPM across 13 brain regions for REST from GTEx v10.
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for REST.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF REST is genetically knocked down using CRISPR/Cas9 in 5xFAD Alzheimer's disease mouse model neurons at 6 months of age, THEN there will be at least a 40% increase in neuronal loss and a 50% increas | Increased neuronal death (NeuN+ cell count) and elevated p-tau levels (ELISA) in REST knockdown mice | — no observation — | pending | 0.55 |
| IF REST is pharmacologically activated in iPSC-derived neurons from Alzheimer's disease patients using a REST agonist (e.g., small molecule enhancer) for 14 days, THEN neuronal survival will increase | Increased neuronal viability (CellTiter-Glo assay) and reduced apoptosis markers (cleaved caspase-3 western blot) after REST activation | — no observation — | pending | 0.65 |